Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
Símbolo de cotizaciónMYO
Nombre de la empresaMyomo Inc
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoMr. Paul R. Gudonis
Número de empleados184
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 12
Dirección137 Portland Street
CiudadBOSTON
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal02114
Teléfono16179969058
Sitio Webhttps://myomo.com/
Símbolo de cotizaciónMYO
Fecha de salida a bolsaJun 12, 2017
Director ejecutivoMr. Paul R. Gudonis
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos